0001140361-23-044842.txt : 20230921
0001140361-23-044842.hdr.sgml : 20230921
20230921213012
ACCESSION NUMBER: 0001140361-23-044842
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230921
DATE AS OF CHANGE: 20230921
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Roivant Sciences Ltd.
CENTRAL INDEX KEY: 0001635088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981173944
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-40782
FILM NUMBER: 231270120
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON HM11
STATE: D0
ZIP: HM11
BUSINESS PHONE: 441-295-5950
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Venker Eric
CENTRAL INDEX KEY: 0001801917
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O ROIVANT SCIENCES, INC.
STREET 2: 320 WEST 37TH STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
144
1
primary_doc.xml
144
0001801917
XXXXXXXX
LIVE
0001635088
Roivant Sciences Ltd.
001-40782
7th Floor 50 Broadway
London
X0
SW1H 0DB
442074003347
Venker Eric
President & COO
Common shares, $0.0000000341740141 par value per share (???Common Shares???)
E*TRADE FINANCIAL CORPORATION
3 EDISON DRIVE
ALPHARETTA
GA
30005
28937
298919.21
771742197
09/21/2023
Nasdaq
Common Shares
09/20/2023
Restricted Stock Units granted under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan
Roivant Sciences Ltd.
N
28937
09/20/2023
N/A
N
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
06/22/2023
15882
158978.82
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor 50 Broadway
London
X0
SW1H 0DB
Common Shares
07/20/2023
159387
1802034.65
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor , 50 Broadway
London
X0
SW1H 0DB
Common Shares
07/21/2023
181998
2025358.44
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
07/21/2023
28937
322068.81
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
07/24/2023
16297
179104.03
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
07/24/2023
33081
361645.23
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
07/25/2023
28344
307869.19
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
07/26/2023
73568
802626.88
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
07/27/2023
23622
259448.15
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
07/31/2023
117372
1397752.56
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
08/01/2023
61397
732070.41
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
08/02/2023
16397
194468.42
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
08/03/2023
44629
532317.84
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
08/14/2023
59811
711152.79
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
08/22/2023
16105
174417.15
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
09/01/2023
14763
175679.7
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
09/05/2023
73275
873438
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
09/06/2023
5926
70223.1
Eric Venker
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
09/08/2023
106430
1297381.7
The securities included in Table I represent a maximum number of shares that may be sold to cover the reporting person's tax obligations when restricted stock units belonging to the reporting person are settled. The securities reported in Table I do not represent discretionary trades by the reporting person, and will be sold, or were sold, as applicable, for the limited purpose of satisfying tax withholding obligations. Table II does not include shares that were "net settled" by the Issuer in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units previously granted to the reporting person.
09/21/2023
02/17/2022
Name: Eric Venker Title: President & COO